Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: JAMA Cardiol. 2016 Aug 1;1(5):548–556. doi: 10.1001/jamacardio.2016.1445

Figure. Mediation Analyses of Fibroblast Growth Factor 23 and Incident Atrial Fibrillation.

Figure

ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; FGF23, fibroblast growth factor 23; HGB, hemoglobin; and LVMI, left ventricular mass index. aThe full model adjusts for age, sex, race/ethnicity, cardiovascular disease, systolic blood pressure, diabetes, smoking, diuretic use, estimated glomerular filtration rate, ratio of urinary albumin to creatinine, and levels of calcium, phosphate, and parathyroid hormone. bThese models include only individuals with available echocardiographic data and are adjusted for the same variables in the full model plus each specific echocardiographic feature.